Unknown

Dataset Information

0

Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD.


ABSTRACT: This study was conducted to investigate whether point-of-care (POC) procalcitonin (PCT) measurement can reduce redundant antibiotic treatment in patients hospitalized with acute exacerbation of COPD (AECOPD).One-hundred and twenty adult patients admitted with AECOPD were enrolled in this open-label randomized trial. Patients were allocated to either the POC PCT-guided intervention arm (n=62) or the control arm, in which antibiotic therapy followed local guidelines (n=58).The median duration of antibiotic exposure was 3.5 (interquartile range [IQR] 0-10) days in the PCT-arm vs 8.5 (IQR 1-11) days in the control arm (P=0.0169, Wilcoxon) for the intention-to-treat population. The proportion of patients using antibiotics for ?5 days within the 28-day follow-up was 41.9% (PCT-arm) vs 67.2% (P=0.006, Fisher's exact) in the intention-to-treat population. For the per-protocol population, the proportions were 21.1% (PCT-arm) vs 73.9% (P<0.00001, Fisher's exact). Within 28-day follow-up, one patient died in the PCT-arm and two died in the control arm. A composite harm end point consisting of death, rehospitalization, or intensive care unit admission, all within 28 days, showed no apparent difference.Our study shows that the implementation of a POC PCT-guided algorithm can be used to substantially reduce antibiotic exposure in patients hospitalized with AECOPD, with no apparent harm.

SUBMITTER: Corti C 

PROVIDER: S-EPMC4922826 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD.

Corti Caspar C   Fally Markus M   Fabricius-Bjerre Andreas A   Mortensen Katrine K   Jensen Birgitte Nybo BN   Andreassen Helle F HF   Porsbjerg Celeste C   Knudsen Jenny Dahl JD   Jensen Jens-Ulrik JU  

International journal of chronic obstructive pulmonary disease 20160622


<h4>Background</h4>This study was conducted to investigate whether point-of-care (POC) procalcitonin (PCT) measurement can reduce redundant antibiotic treatment in patients hospitalized with acute exacerbation of COPD (AECOPD).<h4>Methods</h4>One-hundred and twenty adult patients admitted with AECOPD were enrolled in this open-label randomized trial. Patients were allocated to either the POC PCT-guided intervention arm (n=62) or the control arm, in which antibiotic therapy followed local guideli  ...[more]

Similar Datasets

| S-EPMC3109646 | biostudies-other
| S-EPMC3537542 | biostudies-other
| S-EPMC7576699 | biostudies-literature
| S-EPMC7699579 | biostudies-literature
| S-EPMC7440674 | biostudies-literature
| S-EPMC5018159 | biostudies-literature
| S-EPMC8916484 | biostudies-literature
| S-EPMC7712630 | biostudies-literature
| S-EPMC5744740 | biostudies-literature
| S-EPMC5711260 | biostudies-literature